888

SYNGEN BIOTECH CO LTD

No trades
See on Supercharts

8279 fundamentals

SYNGEN BIOTECH CO LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of 8279 for the last quarter is 467.56 M TWD, and it's 1.29% higher compared to the previous quarter. The net income of Q1 24 is 59.75 M TWD.

Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: TWD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth